Philadelphia Chromosome
7 clinical trials · Condition
◉ Watch Philadelphia Chromosome
| Record | Firm | Date |
|---|---|---|
| Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients (NCT05433532) | The First Affiliated Hospital of Soochow University | 2022-05-01 |
| Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP) (NCT03509896) | Bristol-Myers Squibb | 2017-11-30 |
| Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients (NCT01511289) | Il-Yang Pharm. Co., Ltd. | 2011-08-01 |
| Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI (NCT01602952) | Il-Yang Pharm. Co., Ltd. | 2008-07-01 |
| Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children (NCT00287105) | Rennes University Hospital | 2005-12-01 |
Track Philadelphia Chromosome automatically
Every clearance here is in the API, with alerts when new ones post.